Noah AI Develops AI Clinical Expert to Support End-to-End Clinical Trial Workflows
Exhibitor: SHANGHAI NOAH AI TECHNOLOGY CO., LTD.
Date: 2026-05-22
Booth No.: L426
Noah AI is developing AI Clinical Expert, an AI-powered platform designed to support hospitals, pharmaceutical companies, and clinical research teams across the full clinical research lifecycle.
The platform focuses on key workflows including protocol design, medical writing, protocol review, document management, medical translation, project collaboration, and quality control. Its goal is to help research teams improve efficiency, reduce repetitive work, identify risks earlier, and enhance the standardization and traceability of clinical research processes.
Core Capabilities Already Validated
The project has already completed and validated several core modules.
First, the platform supports clinical study synopsis writing, helping generate key protocol components such as study background, study design, endpoint design, control group design, sample size estimation, and enrollment rate estimation. It also includes a built-in sample size calculator, supports enrollment feasibility estimation based on public data, and helps design guideline-based standard control groups.
Second, Noah AI has developed an IIT protocol review module in collaboration with a leading top-tier hospital in China. The module assists with reviewing research protocols from the perspectives of scientific validity, regulatory consistency, ethical appropriateness, and document completeness. The hospital partner has provided highly positive feedback, and the project has entered a human-versus-AI comparative evaluation stage, with plans to support future academic publication.
Third, the platform provides medical translation capabilities powered by terminology databases. It can translate clinical protocols, informed consent forms, clinical study reports, regulatory documents, and other medical materials while largely preserving the original document layout.
Building Toward Multi-Role Clinical Research Collaboration
Looking ahead, AI Clinical Expert will expand into a full-chain platform covering research site teams, pharmaceutical sponsors, administrators, and cross-functional departments such as PV, DM, STAT, and RA.
Planned capabilities include project progress tracking, task assignment, document circulation, knowledge base management, quality control, medical writing, medical review, and multi-department collaboration.
Through this project, Noah AI aims to make AI a professional assistant embedded throughout clinical research workflows—not only helping users write or translate, but also supporting protocol design, quality control, project collaboration, and compliance management in a more efficient, standardized, and traceable way.
More Exhibitor's Press Release
- Wallonia exhibits at BIO Asia-Taiwan 2026 for the 3rd consecutive year: showcasing biotech strengths WALLONIA EXPORT-INVESTMENT AGENCY,BELGIUM / 2026-07-21
- MarkerX Unveils AI-Driven Next-Gen Mass Spec Proteomics Platform in Strategic Alliance with Nanomics MARKER X CO., LTD. / 2026-07-15
- Dasher Neuroscience Signs MOU with Norwegian Research Center to Join the Platform Trial HYDRA DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- Dasher-KY Progresses Phase II AI Drug for MSA, Initiating International Licensing Steps DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- TaiMed Launches "Rooting for Love" Charity Campaign in Support of Taiwan Lourdes Association TAIMED BIOLOGICS INC. / 2026-07-15
- Exhibition Preview | Youlin Pharma sincerely invites you to attend BIO Asia-Taiwan 2026 SHANGHAI UNIONCLIN CO,. LTD.(UNIONCLIN) / 2026-07-14
- MicroDoctor Cosmetics Showcases Advanced Dissolving Microneedle Technology at BIO Asia MICRODOCTOR BIOMEDICAL CORPORATION / 2026-07-14
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- TaiMed unveil NextGen TMB-365 CD4-Targeted ADC Platform for HIV Functional Cure at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 -EXOLAB ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - MENARINI ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - DEAKOS ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Taiwan Bio partners with Terumo Blood and Cell Technologies to advance automated Treg manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo BCT and Steminent Collaborate to Advance MSC Late-Stage Clinical Manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo Blood and Cell Technologies Introduces APAC CGT Ecosystem Blueprint TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- [Exhibition News] UVAT to Showcase Breakthrough Technologies at BIO Asia-Taiwan 2026! UVAT TECHNOLOGY CO., LTD. / 2026-07-09
- Painless Decoding, Seamless Tracking: Letting Singular Wings Medical's AI Navigate Your Metabolism. SINGULAR WINGS MEDICAL / 2026-07-08
- TaiMed showcase CD4-Targeted platform breakthroughs and High-Quality CDMO Solutions at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-08
- Lonza Advances Integrated DNA to IND Programs Through Acceleration, De-Risking, and Innovation LONZA / 2026-07-08